Apotex Wins Appelate Reversal In Ofloxacin Case

Law360, New York (July 12, 2007, 12:00 AM EDT) -- The U.S. Court of Appeals for the Federal Circuit has reversed a lower court's decision that Canadian generic drug maker Apotex Corp. infringed a patent covering antibacterial ear medicine, ruling that Daiichi Sankyo Co. Ltd.'s patent was invalid due to obviousness, and clearing the way for Apotex to market generic ofloxacin ear drops.

The Federal Circuit handed down its ruling Wednesday, striking down Daiichi's previous win in the U.S. District Court for the District of New Jersey, in which the lower court had held that Apotex...
To view the full article, register now.